Discharge readiness after propofol with or without esketamine for flexible bronchoscopy: A randomized, controlled study

Discharge readiness after propofol with or without esketamine for flexible bronchoscopy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060367

Enrollment

Unknown

Registered

2022-05-29

Start date

2022-05-31

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung disease

Interventions

Group 1 :0.1 mg/kg esketamine

Group 2:0.2 mg/kg esketamine

Group 3:Identical volume 0.9% saline

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years old; 2. American Society of Anesthesiologists (ASA) Class I–III; 3. Elective patients undergoing bronchoscopy.

Exclusion criteria

Exclusion criteria: 1. Allergy to the study drug or contraindication; 2. History of obstructive sleep apnea hypopnea syndrome; 3. Nervous system diseases; 4. Mental illness or history of mental illness; 5. Memory or cognitive impairment; 6. Epilepsy; 7. Abusing or taking drugs that affect the central nervous system; 8. Unable to cooperate with the research for any reason, such as language comprehension difficulties, illiteracy, pregnant women, etc.

Design outcomes

Primary

Measure	Time frame
Proportion of patients ready for discharge within postoperative 30 min;	—

Secondary

Measure	Time frame
Qualtiy of postoperative recovery;Propofol injection pain;	—

Countries

China

Contacts

Public ContactYusheng Yao

Fujian Provincial Hospital

fjslyys@126.com+86 135 5993 9629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026